Reynoso Jamie L.
CEO, Medicare Advantage
Reynoso Jamie L. has filed 27 SEC Form 4 filings (33 transaction rows) across 1 company, with disclosures dating back to 2025. 27 of those filings fall inside the rolling window. Most recent filing: Jul 17, 2026.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$418K
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CLOV | CEO, Medicare Advantage | Sale | 4,839 | $22K | Jul 17 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 13,119 | $61K | Jul 16 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 2,384 | $11K | Jul 9 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 6,229 | $33K | Jul 6 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 2,360 | $11K | Jun 18 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 6,350 | $29K | Jun 16 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 7,289 | $36K | Jun 11 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 5,833 | $11K | Mar 18 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 4,597 | $12K | Jan 20 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 2,102 | $5K | Jan 7 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 4,913 | $13K | Dec 18 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 30,385 | $109K | Nov 5 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 16,514 | $44K | Oct 21 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 2,012 | $5K | Oct 7 | SEC ↗ | |
| CLOV | CEO, Medicare Advantage | Sale | 4,914 | $15K | Sep 19 | SEC ↗ |